Silence Therapeutics (SLN) Revenue (2024 - 2026)

Silence Therapeutics (SLN) posted Revenue of $422000.0 for Q1 2026, up 1141.18% sequentially from $34000.0 in Q4 2025, and up 197.18% YoY from $142000.0 in Q1 2025.

Silence Therapeutics (SLN) Revenue (2024 - 2026) Analysis & Trends

Silence Therapeutics has reported Revenue for 3 years, with the latest figure at $422000.0 in Q1 2026.

  • Quarterly Revenue rose 197.18% year-over-year to $422000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $839000.0 (down 96.98% YoY) and the FY2025 annual result came in at $559000.0, down 98.71% from the prior year.
  • Revenue grew to $422000.0 in Q1 2026 per SLN's latest filing, from $34000.0 in the prior quarter.
  • Over five years, Revenue peaked at $25.3 million in Q4 2024 and troughed at $34000.0 in Q4 2025.
  • A 3-year average of $4.9 million and a median of $422000.0 in 2026 frame the typical range for Revenue.
  • The sharpest annual moves came in 2025 and 2026: Revenue plunged 99.87% in 2025, then surged 197.18% in 2026.
  • Over 3 years, Revenue stood at $25.3 million in 2024, then slumped by 99.87% to $34000.0 in 2025, then jumped by 1141.18% to $422000.0 in 2026.
  • According to Business Quant data, Revenue over the past three periods registered $422000.0, $34000.0, and $159000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 3.33 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 4.29 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 1.56 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 1.71 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 3,001.92
7 Royalty Pharma 33.72 Bn 35.84 Bn - 674.14 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 1.29 Bn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 425.49 Mn
10 Silence Therapeutics 648.22 Mn 576.12 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2026 422,000.00
Dec 31, 2025 34,000.00
Sep 30, 2025 159,000.00
Jun 30, 2025 224,000.00
Mar 31, 2025 142,000.00
Dec 31, 2024 25.31 Mn
Sep 30, 2024 1.50 Mn
Jun 30, 2024 800,000.00
Mar 31, 2024 15.70 Mn